MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 70 filers reported holding MONTE ROSA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,052,465 | -30.1% | 1,472,331 | 0.0% | 2.91% | -41.2% |
| Q2 2023 | $10,085,467 | -12.1% | 1,472,331 | 0.0% | 4.94% | -10.5% |
| Q1 2023 | $11,469,458 | +2.4% | 1,472,331 | 0.0% | 5.52% | -25.4% |
| Q4 2022 | $11,204,439 | -6.9% | 1,472,331 | 0.0% | 7.40% | -7.4% |
| Q3 2022 | $12,029,000 | -15.5% | 1,472,331 | 0.0% | 7.99% | -21.4% |
| Q2 2022 | $14,237,000 | -31.0% | 1,472,331 | 0.0% | 10.16% | -8.8% |
| Q1 2022 | $20,642,000 | -31.3% | 1,472,331 | 0.0% | 11.14% | +5.0% |
| Q4 2021 | $30,065,000 | -8.3% | 1,472,331 | 0.0% | 10.61% | +62.2% |
| Q3 2021 | $32,804,000 | -1.8% | 1,472,331 | 0.0% | 6.54% | +22.2% |
| Q2 2021 | $33,422,000 | – | 1,472,331 | – | 5.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $10,085,467 | 4.94% |
| NEA Management Company, LLC | 7,692,298 | $52,692,241 | 4.02% |
| Alphabet Inc. | 1,464,015 | $10,028,502 | 0.54% |
| Avoro Capital Advisors LLC | 4,535,000 | $31,064,750 | 0.42% |
| Casdin Capital, LLC | 510,882 | $3,499,542 | 0.31% |
| Baker Brothers Advisors | 3,023,951 | $20,714,064 | 0.12% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 31,156 | $213,419 | 0.07% |
| ExodusPoint Capital Management, LP | 669,495 | $4,586 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $193,115 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 100,478 | $688,274 | 0.02% |